-
2261por Tichenor, Marlee, Winters, Janelle, Storeng, Katerini T., Bump, Jesse, Gaudillière, Jean-Paul, Gorsky, Martin, Hellowell, Mark, Kadama, Patrick, Kenny, Katherine, Shawar, Yusra Ribhi, Songane, Francisco, Walker, Alexis, Whitacre, Ryan, Asthana, Sumegha, Fernandes, Genevie, Stein, Felix, Sridhar, Devi“…The unique relationships between Bank entities and countries that shape health policy, and the Bank’s position as a center of research, permit it to have a formative influence on health economics as applied to international development. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2262por Boß, Leif, Angerer, Peter, Dragano, Nico, Ebert, David, Engels, Miriam, Heber, Elena, Kuhlmann, Rebekka, Ruhle, Sascha, Schwens, Christian, Wulf, Ines Catharina, Lehr, Dirk“…This trial will also compare the two interventions from a health economics perspective, and conduct explorative analyses to identify potential effect moderators. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2263por Evitt, Lee A, Kumar, Rahul, Kamath, Rahul, Jha, Diwakar, Parks, Daniel, van Wyk, Jean A, de Ruiter, Annemiek“…DISCLOSURES: Lee A. Evitt, MSc Health Economics, ViiV Healthcare (Employee, Shareholder of GSK) Rahul Kumar, M Pharmacy, GlaxoSmithKline (Employee) Rahul Kamath, PharmD, GlaxoSmithKline (Employee) Diwakar Jha, Masters in Pharmaceutical Sciences, GlaxoSmithKline (Employee) Daniel Parks, PhD, GlaxoSmithKline (Employee, Shareholder) Jean A. van Wyk, MB,ChB, GlaxoSmithKline (Shareholder)ViiV Healthcare (Employee) Annemiek de Ruiter, MBBS FRCP, GlaxoSmithKline (Shareholder)ViiV Healthcare (Employee)…”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2264por Clark, Marci, Romano, Carla, Olayinka-Amao, Oyebimpe, Whalley, Diane, Crawford, Rebecca, Pathak, Purnima, Brindicci, Caterina, Garg, Kristin, Kordy, Kattayoun, Everhard, Francois, Patalano, Francesco, Roesler, Zach, Sutton, Thomas, Göransson, Oskar, Landles, Ross, Naujoks, Christel, Marvel, Jessica, Keininger, Dorothy L.“…This study aimed to develop a novel, interactive, electronic Pediatric Asthma Symptom Diary (ePASD) measuring self-reported key symptom severity and proximal impacts of asthma in young children with varying reading ability and disease severity, consistent with US Food and Drug Administration (FDA) PRO guidance and the International Society for Health Economics and Outcomes Research (ISPOR) good research practices. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2265“…The secondary objectives are mainly to assess the health-economic and clinical benefits from using the CDSS, and the improvement of GPs’ AF management capability. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2266por Stafford, Sara, Bech, Peter G., Fridhammar, Adam, Miresashvili, Nino, Nilsson, Andreas, Willis, Michael, Liu, Aiden“…The cost-effectiveness of once-weekly semaglutide 1 mg versus canagliflozin 300 mg for treating T2DM was estimated using the Swedish Institute for Health Economics-Diabetes Cohort Model (IHE-DCM) and the Economic and Health Outcomes Model of T2DM (ECHO-T2DM). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2267por Piper, Donella, Jorm, Christine, Iedema, Rick, Goodwin, Nicholas, Searles, Andrew, McFayden, Lisa“…CONCLUSIONS: This study provides the first detailed case description of an embedded health economics program. The results demonstrate how the process, context and relational factors of engaging and embedding the support of a health economist works and why. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2268por Yan, Xin, Pang, Ying, Yan, Lirong, Ma, Zhigang, Jiang, Ming, Wang, Weiwei, Chen, Jie, Han, Yangtong, Guo, Xiaolei, Hu, Hongtao“…This study aimed to investigate the incidence of perioperative stroke, health economic burden, clinical outcomes, and associated risk factors. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2269“…METHODS: We searched PubMed, the School of Health and Related Research Health Utility Database (ScHARRHUD), and the Health Economics Research Centre (HERC) database of mapping studies (version 7.0) to identify any studies mapping Pruritus-VAS, Skindex-29, or MF/SS-CTCL QoL to a preference-based instrument (ideally, EQ-5D), and any studies assessing HSUVs in MF-CTCL. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2270por Hata, Akiko, Komiyama, Maki, Yasoda, Akihiro, Wada, Hiromichi, Yamakage, Hajime, Satoh-Asahara, Noriko, Morimoto, Tatsuya, Takahashi, Yuko, Hasegawa, Koji“…BACKGROUND: Cessation of smoking can markedly reduce the incidence of cardiovascular disease, improve health economics, and benefit society. Aromatherapy has the potential to be a novel option as an adjuvant therapy for smoking cessation that may alleviate depressive symptoms. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2271“…The Institute of Health Economics risk of bias (RoB) tool assessed studies' internal validity. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2272Publicado 2022“…We will apply the world coffee method, in which each table will display one individual discipline (epidemiology, health economics, psychology, law, ethics, and computer science). …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2273por Lalu, Manoj M., Kekre, Natasha, Montroy, Joshua, Ghiasi, Maryam, Hay, Kevin, McComb, Scott, Weeratna, Risini, Atkins, Harold, Hutton, Brian, Yahya, Ayel, Masurekar, Ashish, Sobh, Mohamad, Fergusson, Dean A.“…A modified Institute of Health Economics tool will be used to evaluate the risk of bias of included studies. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2274por Liu, Lei, Ruan, Zhen, Ung, Carolina Oi Lam, Zhang, Yawen, Shen, Yang, Han, Sheng, Jia, Ruxu, Qiao, Jingtao, Hu, Hao, Guo, Lixin“…METHODS: The study applied the Swedish Institute of Health Economics Diabetes Cohort Model to evaluate the long-term clinical and economic outcomes of once-weekly treatment of semaglutide at 0.5 mg and 1.0 mg, respectively, versus PEG-loxenatide 0.2 mg, over a 40-year time horizon. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2275por Pokhilenko, Irina, Janssen, Luca M. M., Paulus, Aggie T. G., Drost, Ruben M. W. A., Hollingworth, William, Thorn, Joanna C., Noble, Sian, Simon, Judit, Fischer, Claudia, Mayer, Susanne, Salvador-Carulla, Luis, Konnopka, Alexander, Hakkaart van Roijen, Leona, Brodszky, Valentin, Park, A-La, Evers, Silvia M. A. A.“…CONCLUSION: This is the first study that transparently describes the development process of a generic multi-sectoral RUM instrument in health economics and provides insights into the methodological aspects and overall validity of its development process. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2276por Swanson, Jonathan R., Becker, Amy, Fox, Jenny, Horgan, Michael, Moores, Russell, Pardalos, John, Pinheiro, Joaquim, Stewart, Dan, Robinson, Tonya“…Despite evidence supporting the clinical benefits of an EHMD (such as reducing the frequency of morbidities), barriers prevent its widespread adoption, including limited health economics and outcomes data, cost concerns, and lack of standardized feeding guidelines. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2277por Aouad, Phillip, Ahmed, Moin Uddin, Nassar, Natasha, Miskovic-Wheatley, Jane, Touyz, Stephen, Maguire, Sarah, Cunich, Michelle“…A rigorous assessment of up-to-date health economic evidence on interventions for EDs is essential for informing decision-making in this area. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2278por Croteau, Stacy E, Cook, Keziah, Sheikh, Lamiya, Chawla, Anita, Sammon, Joshua, Solari, Paul, Kim, Benjamin, Hinds, David, Thornburg, Courtney D“…Nonfactor prophylaxis and gene therapy are emerging novel prophylaxis strategies for hemophilia A, and it is important to compare their health economics with that of FVIII prophylaxis. Current data on resource utilization and costs in the adult hemophilia A prophylaxis population are limited, and a structured approach to analyze annual costs in these patients using administrative claims data has not been previously reported. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2279por Ferrer, Monica Pujadas, Delfino, Marcos, Badia, Federica, Kenny, Juan, Assandri, Elizabeth, Olivera, Ignacio, Canziani, Catalina C, Pírez, María Catalina“…Since 2010 to 2018, the most widely used vaccine contained MAV/06 DISCLOSURES: Marcos Delfino, Pediatrician, pediatric infectologist, Adjunct Professor of pediatric clinic, Pfizer: Finnancial support to travel to IDWeek 2023 Ignacio Olivera, Medical Doctor, Master in Health Economics and Pharmaceutical Economics, Pfizer: Grant/Research Support|Roche: Expert Testimony|Sanofis Pasteur: Grant/Research Support María Catalina Pírez, Pediatrician, Pediatric infectologist, microbiologist Professor of pediatric, Degree V, Merck, Pfizer: Expert Testimony|Merck, Pfizer: Honoraria…”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2280por Calderon, Moises A, Demoly, Pascal, Gerth van Wijk, Roy, Bousquet, Jean, Sheikh, Aziz, Frew, Anthony, Scadding, Glenis, Bachert, Claus, Malling, Hans J, Valenta, Rudolph, Bilo, Beatrice, Nieto, Antonio, Akdis, Cezmi, Just, Jocelyne, Vidal, Carmen, Varga, Eva M, Alvarez-Cuesta, Emilio, Bohle, Barbara, Bufe, Albrecht, Canonica, Walter G, Cardona, Victoria, Dahl, Ronald, Didier, Alain, Durham, Stephen R, Eng, Peter, Fernandez-Rivas, Montserrat, Jacobsen, Lars, Jutel, Marek, Kleine-Tebbe, Jörg, Klimek, Ludger, Lötvall, Jan, Moreno, Carmen, Mosges, Ralph, Muraro, Antonella, Niggemann, Bodo, Pajno, Giovanni, Passalacqua, Giovanni, Pfaar, Oliver, Rak, Sabina, Senna, Gianenrico, Senti, Gabriela, Valovirta, Erkka, van Hage, Marianne, Virchow, Johannes C, Wahn, Ulrich, Papadopoulos, Nikolaos“…Not only do allergic patients suffer from a debilitating disease, with the potential for major impact on their quality of life, career progression, personal development and lifestyle choices, but they also constitute a significant burden on health economics and macroeconomics due to the days of lost productivity and underperformance. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto